Please assess the completion status of the following clinical trial:

Trial Title: Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 18 years-old or older~* Male patients~* Female patients~* Patients able to speak and understand written English~* Patients presenting to the orthopedic institute clinic with shoulder pain and necessitating the procedure of arthroscopic shoulder surgery~* Specific arthroscopic procedures include: intra-articular debridement, decompression, acromioplasty, and acromioclavicular joint resection~Exclusion Criteria:~* Patients undergoing arthroscopic shoulder surgery that includes other interventions (i.e. rotator cuff repair; labral repair, etc)~* Patients with adhesive capsulitis~* Patients with significant cervical spine symptoms and/or pathology~* Patients having a history of receiving chronic pain treatment~* Patients who are currently pregnant or who become pregnant before surgery~* Patients who cannot speak or understand written english~* Patients who are under the age of 18 years of age~* As per exclusionary criteria if a subject is pregnant they will not be eligible for participation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group A (Type: PLACEBO_COMPARATOR): After arthroscopic surgery the control group (Group A) will undergo a subacromial marcaine injection (standard of care).
- Group B (Type: EXPERIMENTAL): After arthroscopic surgery the experimental group (Group B) will undergo a subacromial corticosteroid injection+marcaine.

Based on this trial design, predict the completion outcome and termination type (if applicable).